184 related articles for article (PubMed ID: 24076207)
1. Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.
Hamilton KL; Harris AC; Gewirtz JC
Brain Res; 2013 Nov; 1538():73-82. PubMed ID: 24076207
[TBL] [Abstract][Full Text] [Related]
2. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states.
Fendt M; Mucha RF
Psychopharmacology (Berl); 2001 May; 155(3):242-50. PubMed ID: 11432686
[TBL] [Abstract][Full Text] [Related]
3. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Rothwell PE; Thomas MJ; Gewirtz JC
Neuropsychopharmacology; 2009 Sep; 34(10):2285-95. PubMed ID: 19494807
[TBL] [Abstract][Full Text] [Related]
4. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.
Harris AC; Gewirtz JC
Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079
[TBL] [Abstract][Full Text] [Related]
5. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.
Harris AC; Hanes SL; Gewirtz JC
Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881
[TBL] [Abstract][Full Text] [Related]
7. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
8. HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal.
Hamilton KL; Harris AC; Gewirtz JC; Sparber SB; Schrott LM
Neurotoxicol Teratol; 2005; 27(1):95-103. PubMed ID: 15681124
[TBL] [Abstract][Full Text] [Related]
9. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
Harris AC; Atkinson DM; Aase DM; Gewirtz JC
Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
Glover EM; Davis M
Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
[TBL] [Abstract][Full Text] [Related]
11. Protracted manifestations of acute dependence after a single morphine exposure.
Rothwell PE; Thomas MJ; Gewirtz JC
Psychopharmacology (Berl); 2012 Feb; 219(4):991-8. PubMed ID: 21833504
[TBL] [Abstract][Full Text] [Related]
12. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
Brandt MR; France CP
J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
[TBL] [Abstract][Full Text] [Related]
13. Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.
Radke AK; Holtz NA; Gewirtz JC; Carroll ME
Psychopharmacology (Berl); 2013 May; 227(1):117-26. PubMed ID: 23254375
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
15. Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats.
Radke AK; Gewirtz JC; Carroll ME
Behav Pharmacol; 2015 Aug; 26(5):485-8. PubMed ID: 26154436
[TBL] [Abstract][Full Text] [Related]
16. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
Schulteis G; Heyser CJ; Koob GF
Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
[TBL] [Abstract][Full Text] [Related]
17. Prenatal opiate withdrawal activates the chick embryo hypothalamic pituitary-adrenal axis and dilates vitelline blood vessels via serotonin(2) receptors.
Schrott LM; Baumgart MI; Zhang X; Sparber SB
J Pharmacol Exp Ther; 2002 Oct; 303(1):257-64. PubMed ID: 12235259
[TBL] [Abstract][Full Text] [Related]
18. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Caillé S; Espejo EF; Koob GF; Stinus L
Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
[TBL] [Abstract][Full Text] [Related]
19. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
20. Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats.
Engelmann JM; Radke AK; Gewirtz JC
Psychopharmacology (Berl); 2009 Nov; 207(1):13-25. PubMed ID: 19669732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
